Solvonis Therapeutics plc (LON:SVNS)
London · Delayed Price · Currency is GBP · Price in GBX 0.1002
-0.0048 (-4.57%)
Oct 15, 2026, 2:56 PM GMT
Solvonis Therapeutics Market Cap
Solvonis Therapeutics has a market cap or net worth of 6.82 million as of October 15, 2026. It is the 41,924th most valuable company in the world and the 936th biggest in the United Kingdom. Its market cap has decreased by 70.42% in one year.
Market Cap
6.82M
Enterprise Value
6.23M
Revenue
n/a
Global Rank
Country Rank
#936 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since January 6, 2022, Solvonis Therapeutics's market cap has decreased from 23.03M to 6.82M, a decrease of -70.39%. That is a compound annual growth rate of -22.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 6.82M | -67.68% |
| Dec 31, 2025 | 21.10M | 348.30% |
| Dec 31, 2024 | 4.71M | 686.33% |
| Dec 29, 2023 | 598.56K | -95.86% |
| Dec 30, 2022 | 14.47M | -37.18% |
| Jan 6, 2022 | 23.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SkinBioTherapeutics | 15.42M |
| Oxford BioDynamics | 14.13M |
| Fusion Antibodies | 12.35M |
| Palatin Technologies | 12.20M |
| Aptamer Group | 11.39M |
| Thalia Therapeutics | 10.70M |
| Genflow Biosciences | 10.01M |
| CRISM Therapeutics | 7.01M |